Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation
- PMID: 24299154
- DOI: 10.1111/1471-0528.12488
Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation
Abstract
Background: Positron emission tomography-computed tomography (PET-CT) is recommended to triage women for exenterative surgery and surveillance after treatment for advanced cervical cancer.
Objective: To evaluate diagnostic accuracy of additional whole body PET-CT compared with CT/magnetic resonance imaging (MRI) alone in women with suspected recurrent/persistent cervical cancer and in asymptomatic women as surveillance.
Design: Systematic reviews. Subjective elicitation to supplement diagnostic information.
Search strategy/selection criteria/data collection and analysis: Searches of electronic databases were performed to June 2013. Studies in women with suspected recurrent/persistent cervical cancer and in asymptomatic women undergoing follow up with sufficient numeric data were included. We calculated sensitivity, specificity and corresponding 95% confidence intervals. Meta-analyses employed a bivariate model that included a random-effects term for between-study variations (CT studies) and univariate random effects meta-analyses (PET-CT studies) for sensitivity and specificity separately.
Subjective elicitation: Prevalence of recurrence and the accuracy of imaging elicited using the allocation of points technique. Coherence of elicited subjective probabilities with estimates in the literature examined.
Results: We identified 15 relevant studies; none directly compared additional PET-CT with MRI or CT separately. Most CT and MRI studies used older protocols and the majority did not distinguish between asymptomatic and symptomatic women. Meta-analysis of nine PET-CT studies in mostly symptomatic women showed sensitivity of 94.8 (95% CI 91.2-96.9), and specificity of 86.9% (95% CI 82.2-90.5). The summary estimate of the sensitivity of CT for detection of recurrence was 89.64% (95% CI 81.59-94.41) and specificity was 76% (95% CI 43.68-92.82). Meta-analysis for MRI test accuracy studies was not possible because of clinical heterogeneity. The sensitivity and specificity of MRI in pelvic recurrence varied between 82 and 100% and between 78 and 100%, respectively. Formal statistical comparisons of the accuracy of index tests were not possible. Subjective elicitation provided estimates comparable to the literature. Subjective estimates of the increase in accuracy from the addition of PET-CT were less than elicited increases required to justify the use in PET-CT for surveillance.
Conclusion: Evidence to support additional PET-CT is scarce, of average quality and does not distinguish between application for surveillance and diagnosis. Guidelines recommending PET-CT in recurrent cervical cancer need to be reconsidered in the light of the existing evidence base.
Keywords: Accuracy; computed tomography; exenteration; magnetic resonance imaging; positron emission tomography-computed tomography; recurrent cervical cancer.
© 2013 Royal College of Obstetricians and Gynaecologists.
Similar articles
-
Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.Cochrane Database Syst Rev. 2019 Jul 1;7(7):CD012806. doi: 10.1002/14651858.CD012806.pub2. Cochrane Database Syst Rev. 2019. PMID: 31260100 Free PMC article.
-
Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.BJOG. 2014 Mar;121(4):464-76. doi: 10.1111/1471-0528.12460. Epub 2013 Dec 3. BJOG. 2014. PMID: 24299112
-
Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol.Medicine (Baltimore). 2018 Nov;97(48):e12900. doi: 10.1097/MD.0000000000012900. Medicine (Baltimore). 2018. PMID: 30508883 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.Medicine (Baltimore). 2020 Aug 28;99(35):e20932. doi: 10.1097/MD.0000000000020932. Medicine (Baltimore). 2020. PMID: 32871859 Free PMC article.
Cited by
-
Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update.Curr Oncol. 2016 Apr;23(2):109-18. doi: 10.3747/co.23.2742. Epub 2016 Apr 13. Curr Oncol. 2016. PMID: 27122975 Free PMC article.
-
Predictive Role of MRI and 18F FDG PET Response to Concurrent Chemoradiation in T2b Cervical Cancer on Clinical Outcome: A Retrospective Single Center Study.Cancers (Basel). 2020 Mar 12;12(3):659. doi: 10.3390/cancers12030659. Cancers (Basel). 2020. PMID: 32178252 Free PMC article.
-
Robotic-Assisted Pelvic Exenteration for Cervical Cancer: A Systematic Review and Novel Insights into Compartment-Based Imaging.J Clin Med. 2024 Jun 24;13(13):3673. doi: 10.3390/jcm13133673. J Clin Med. 2024. PMID: 38999239 Free PMC article. Review.
-
Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis.Contrast Media Mol Imaging. 2021 Mar 2;2021:8874990. doi: 10.1155/2021/8874990. eCollection 2021. Contrast Media Mol Imaging. 2021. PMID: 33746650 Free PMC article. Review.
-
SEOM guidelines for cervical cancer.Clin Transl Oncol. 2015 Dec;17(12):1036-42. doi: 10.1007/s12094-015-1452-2. Epub 2015 Dec 9. Clin Transl Oncol. 2015. PMID: 26650487 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical